Axsome Therapeutics
AXSM
AXSM
350 hedge funds and large institutions have $4.51B invested in Axsome Therapeutics in 2025 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 145 increasing their positions, 101 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more call options, than puts
Call options by funds: $87.3M | Put options by funds: $81.5M
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
2.36% less ownership
Funds ownership: 76.86% → 74.5% (-2.4%)
Holders
350
Holding in Top 10
7
Calls
$87.3M
Puts
$81.5M
Top Buyers
| 1 | +$74M | |
| 2 | +$51.6M | |
| 3 | +$50.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$39M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$36.4M |
Top Sellers
| 1 | -$146M | |
| 2 | -$48.3M | |
| 3 | -$47.6M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$46.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.4M |